產品詳情
簡單介紹：
Anti-Constitutive androstane receptor抗體產品質量穩定，實驗效果明顯，貨期快，價格優惠，歡迎垂詢訂購！我公司長期供應**組化抗體、WB抗體、**組化試劑盒和抗體試驗所需全部相關試劑、熒光標記抗體、單克隆抗體、多克隆抗體、各種標記的二抗IgG/IgM/IgD/IgA等科研實驗抗體。Anti-Constitutive androstane receptor抗體用于**組化實驗,WB實驗,相應的標記抗體有HRP標記抗體,FITC標記,BIO等。
詳情介紹：
Rabbit Anti-Constitutive androstane receptor
Cat. Number:
Anti-Constitutive androstane receptor抗體KL-13972R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
This gene encodes a member of the nuclear receptor superfamily, and is a key regulator of xenobiotic and endobiotic metabolism. The protein binds to DNA as a monomer or a heterodimer with the retinoid X receptor andAnti-Constitutive androstane receptor抗體 regulates the transcription of target genes involved in drug metabolism and bilirubin clearance, such as cytochrome P450 family members. Unlike most nuclear receptors, this transcriptional regulator is constitutively active in the absence of ligand but is regulated by both agonists and inverse agonists. Ligand binding results in translocation of this protein to the nucleus, where it activates or represses target gene transcription. These ligands include bilirubin, a variety of foreign compounds, steroid hormones, and prescription drugs. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
Also known as:
CAR; CAR BETA; CAR1; CARA; Constitutive activator of retinoid response; Constitutive active response; Constitutive androstaneAnti-Constitutive androstane receptor抗體 receptor; MGC97144; NR1I3; NR1I3_HUMAN; Nuclear receptor subfamily 1 group I member 3; Orphan nuclear receptor MB67; Orphan nuclear receptor NR1I3.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Chimpanzee, .
●
Immunogen: KLH conjugated synthetic peptide derived from human Constitu.
●
Predicted Molecular Weight: Anti-Constitutive androstane receptor抗體45kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500
Not yet tested in other applications.
Optimal working dilutions must be Anti-Constitutive androstane receptor抗體determined by the end user.
Not yet tested in other applications.
Optimal working dilutions must be Anti-Constitutive androstane receptor抗體determined by the end user.
kl134Bo01 腫瘤壞死因子β(TNFβ)多克隆抗體 Polyclonal Antibody to Tumor Necrosis Factor Beta (TNFb)
kl134Ca01 腫瘤壞死因子β(TNFβ)多克隆抗體 Polyclonal Antibody to Tumor Necrosis Factor Beta (TNFb)
kl134Hu01 腫瘤壞死因子β(TNFβ)多克隆抗體 Polyclonal Antibody to Tumor Necrosis Factor Beta (TNFb)
kl134Mu01 腫瘤壞死因子β(TNFβ)多克隆抗體 Polyclonal Antibody to Tumor Necrosis Factor Beta (TNFb)
kl134Po01 腫瘤壞死因子β(TNFβ)多克隆抗體 Polyclonal Antibody to Tumor Necrosis Factor Beta (TNFb)
kl134Ra01 腫瘤壞死因子β(TNFβ)多克隆抗體 Polyclonal Antibody to Tumor Necrosis Factor Beta (TNFb)
kl134Rb51 腫瘤壞死因子β(TNFβ)多克隆抗體 Polyclonal Antibody to Tumor Necrosis Factor Beta (TNFb)
kl134Si01 腫瘤壞死因子β(TNFβ)多克隆抗體 Polyclonal Antibody to Tumor Necrosis Factor Beta (TNFb)
kl135Bo01 血小板生成素(TPO)多克隆抗體 Polyclonal Antibody to Thrombopoietin (TPO)
kl135Ca01 血小板生成素(TPO)多克隆抗體 Polyclonal Antibody to Thrombopoietin (TPO)
kl135Ga01 血小板生成素(TPO)多克隆抗體 Polyclonal Antibody to Thrombopoietin (TPO)
kl135Hu01 血小板生成素(TPO)多克隆抗體 Polyclonal Antibody to Thrombopoietin (TPO)
kl135Mu01 血小板生成素(TPO)多克隆抗體 Polyclonal Antibody to Thrombopoietin (TPO)
kl135Po01 血小板生成素(TPO)多克隆抗體 Polyclonal Antibody to Thrombopoietin (TPO)
kl135Ra01 血小板生成素(TPO)多克隆抗體 Polyclonal Antibody to Thrombopoietin (TPO)
kl139Ca01 腫瘤壞死因子相關凋亡誘導配體(TRAIL)多克隆抗體 Polyclonal Antibody to Tumor Necrosis Factor Related Apoptosis Inducing Ligand (TRAIL)
kl139Hu01 腫瘤壞死因子相關凋亡誘導配體(TRAIL)多克隆抗體 Polyclonal Antibody to Tumor Necrosis Factor Related Apoptosis Inducing Ligand (TRAIL)
kl139Mu01 腫瘤壞死因子相關凋亡誘導配體(TRAIL)多克隆抗體 Polyclonal Antibody to Tumor Necrosis Factor Related Apoptosis Inducing Ligand (TRAIL)
kl139Ra01 腫瘤壞死因子相關凋亡誘導配體(TRAIL)多克隆抗體 Polyclonal Antibody to Tumor Necrosis Factor Related Apoptosis Inducing Ligand (TRAIL)
